INS and Ataxia: Interestingly, our new mouse model that exhibits a partial deletion of RORα lacks the troublesome ataxia that leads to abnormal movement and feeding, but we were still able to clearly link lower RORα activity to improved glucose metabolism, reduced insulin resistance, resistance to diet- or age-induced obesity, and reduced inflammation.